XAF1 and gastric cancer: Interestingly, treatment of gastric cancer cells with TSA, a histone deacetylase inhibitor also restored XAF1 expression, alone or combined with 5-Aza-CdR treatment, indicating that histone modification may also be involved in XAF1 regulation.